Image

LEA HUGUET
Ingénieur d'études
Recherche - Paris
Spécialités / domaines
Cancer,
Investigation préclinique
Fonctions au sein de l'Institut Curie :
- Ingénieur d'études
Publications
Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers
Journal of Hematology & Oncology
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers
Science Translational Medicine